Itonic (NASDAQ:ITOC) Stock Scheduled to Reverse Split on Tuesday, October 6th

Shares of Itonic Holdings Ltd. (NASDAQ:ITOC) are scheduled to reverse split on Tuesday, October 6th. The 1-16 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the closing bell on Monday, October 5th.

Itonic Stock Performance

ITOC stock traded down $0.04 during midday trading on Friday, reaching $0.25. The company’s stock had a trading volume of 212,645 shares, compared to its average volume of 995,162. Itonic has a 1 year low of $0.22 and a 1 year high of $1.15. The stock has a fifty day simple moving average of $0.29 and a two-hundred day simple moving average of $0.31.

Itonic (NASDAQ:ITOC) last posted its quarterly earnings results on Wednesday, September 30th. The company reported ($0.05) EPS for the quarter. The firm had revenue of $0.05 million for the quarter.

Analysts Set New Price Targets

Separately, Weiss Ratings downgraded shares of Itonic from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday, September 24th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Itonic has an average rating of “Sell”.

About Itonic

iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients.